California Supreme Court: Brand-Name Drug Maker Liable Even After Divestment

Mealey's (January 3, 2018, 9:22 AM EST) -- SAN FRANCISCO — In a 4-3 ruling, the California Supreme Court on Dec. 21 ruled that Novartis Pharmaceuticals Corp. can be liable for failing to include a warning about fetal brain injury in labels used by generic drug makers and that the liability can extend to six years after Novartis sold its rights to the drug (T.H., et al. v. Novartis Pharmaceuticals Corporation, No. S233898, Calif. Sup., 2017 Cal. LEXIS 9636)....

Attached Documents

Related Sections